Valentina Robila Selected Research

Trastuzumab (Herceptin)

3/2024

Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valentina Robila Research Topics

Disease

5	Neoplasms (Cancer) 03/2024 - 12/2008
3	Melanoma (Melanoma, Malignant) 04/2009 - 03/2005
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 12/2018
1	Breast Neoplasms (Breast Cancer) 03/2024
1	Ventricular Tachycardia 01/2023
1	Mesothelioma 01/2022
1	Malignant Mesothelioma 01/2022
1	Necrosis 12/2021
1	Ischemia 12/2021
1	Humeral Fractures 12/2021
1	Margins of Excision 10/2021
1	Carcinogenesis 01/2019
1	Leiomyomatosis 12/2018

Drug/Important Bio-Agent (IBA)

1	human ERBB2 proteinIBA 03/2024
1	Trastuzumab (Herceptin)FDA Link 03/2024
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2024
1	Cyclin D1IBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	IodineIBA 12/2021
1	CollagenIBA 01/2019
1	Diphtheria ToxinIBA 01/2019
1	Fumarate Hydratase (Fumarase)IBA 12/2018
1	Proteasome InhibitorsIBA 04/2009
1	Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseIBA 04/2009
1	Proteins (Proteins, Gene)FDA Link 12/2008
1	HLA-DR Antigens (HLA-DR)IBA 12/2008
1	EpitopesIBA 12/2008
1	Histocompatibility Antigens Class IIIBA 12/2008
1	Monophenol Monooxygenase (Tyrosinase)IBA 03/2005

Therapy/Procedure

2	Therapeutics 03/2024 - 01/2019
1	Heart Transplantation (Grafting, Heart) 01/2023
1	Arthroplasty 12/2021
1	Segmental Mastectomy (Lumpectomy) 10/2021
1	Transplantation 07/2012